|FOR IMMEDIATE RELEASE
Tuesday, Mar. 18, 1997
Consensus Development Conference on Management of Hepatitis C
- What is the natural
history of hepatitis C?
- What is the most
appropriate approach to diagnose and monitor patients?
- What recommendations can
be made to patients to prevent transmission?
- Which patients should be
- What is the most effective
approach to therapy?
- What are the most
important areas for future research on hepatitis C?
The panel will present its draft statement to the public for comment
on the morning of the third and final day of the conference. Following
this public comment session, the panel will release its final consensus
statement at the news conference and take questions from the media.
The consensus statement is the report of an independent panel and is
not a policy statement of the NIH or the Federal Government.
The consensus panel will be chaired by Donald Powell,
M.D., Professor and Chairman, Department of Internal Medicine,
University of Texas Medical Branch at Galveston. Dr. Powell will
moderate the news conference.
The NIH Consensus Development Program was established in 1977 as a
form of "science court" to resolve in an unbiased manner controversial
topics in medicine. To date, NIH has conducted 120 such conferences
addressing a wide range of controversial medical issues important to
health care providers, patients, and the general public. An average of
six consensus conferences are held each year.
Additional information about this conference, including the meeting
agenda and area hotels, is also available at the NIH Consensus
Development Program web site at http://consensus.nih.gov. To register
for the conference, call 301-770-3153.